Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy

Clinical Cancer Research

Volumn 18, Issue 11, 2012, Pages 3180-3187

  Boyette Davis, Jessica A ^a   Eng, Cathy ^b   Wang, Xin S ^b   Cleeland, Charles S ^b   Wendelschafer Crabb, Gwen ^c   Kennedy, William R ^c   Simone, Donald A ^d   Zhang, Haijun ^b   Dougherty, Patrick M ^b  

^a York College   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BUMPS DETECTION TEST; CANCER CHEMOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SKIN FUNCTION; SKIN TEMPERATURE; TEMPERATURE SENSE; TOUCH;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION; SKIN TEMPERATURE;

EID: 84861777271     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0205     Document Type: Article

References (45)

1. Giglio P, Gilbert MR. Neurologic complications of cancer and its treatment. Curr Oncol Rep 2010;12:50-9.
2. Cerase A, Brindisi L, Lazzeretti L, Pepponi E, Venturi C. Lung cancer presenting with trigeminal neuropathy. Neurol Sci 2011;32:927-31.
3. Malloy KA, Chigbu DI. Anterior temporal chordoid meningioma causing compressive optic neuropathy. Optom Vis Sci 2011;88:645-51.
4. Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011;24: 504-10.
5. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:591-601.
6. Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 2005;18:598-603. (Pubitemid 41476150)
7. Chalk CH, Windebank AJ, Kimmel DW, McManis PG. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 1992;19:346-51.
8. Cata JP, Weng H-R, Dougherty PM. Basic neurobiology of cancer pain. In: Fisch MF, Burton AW, editors, Cancer pain management. New York: McGraw-Hill; 2006. p. 57-72.
9. Polomano RC, Farrar JT. Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs 2006;106:39-47.
10. Boyette-Davis JA, Cata JP, Zhang H, Driver LC, Wendelschafer-Crabb G, Kennedy WR, et al. Follow-up psychophysical studies in bortezomib- related chemoneuropathy patients. J Pain 2011;12:1017-24.
11. Cata JP, Weng H-R, Dougherty PM. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 2006;72:151-69.
12. Cata JP, Weng H-R, Burton AW, Villareal H, Giralt S, Dougherty PM. Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 2007;8:296-306. (Pubitemid 46551871)
13. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng H-R. Taxolinduced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004;109:132-42. (Pubitemid 38479779)
14. Dougherty PM, Cata JP, Burton AW, Vu K, Weng HR. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 2007;33:166-79. (Pubitemid 46186866)
15. Gracely RH. Studies of pain in normal man. In:Wall PD, Melzack R, editors. Textbook of pain. 3rd ed. Edinburgh, UK: Churchill Livingstone; 1994. p. 315-36.
16. Kennedy WR, Selim MM, Brink TS, Hodges JS, Wendelschafer-Crabb G, Foster SX, et al. A new device to quantify tactile sensation in neuropathy. Neurology 2011;76:1642-9.
17. Ruff RM, Parker SB. Gender and age-specific changes in motor speed and eye-hand coordination in adults: normative values for finger tapping and grooved pegboard tests. Percept Motor Skills 1993;76: 1219-30.
18. Fuchs PN, Campbell JN, Meyer RA. Secondary hyperalgesia persists in capsaicin desensitized skin. Pain 2000;84:141-9. (Pubitemid 30074215)
19. Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ. Long term effects of vincristine on the peripheral nervous system. J Neuro Oncol 1993;15:23-7. (Pubitemid 23049695)
20. Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neuro Oncol 1997;35: 47-53. (Pubitemid 27361845)
21. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Marzola M, Colombo N, et al. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin. Cancer 1995;75:1141-50.
22. Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepère C, et al. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 2009;144:245-52.
23. Zhuang L, Bai J, Huang H, Tang C, Yang J, Zhou B, et al. Meta-analysis of chemotherapy with irinotecan or oxaliplatin-involved regimen for untreated metastatic advanced colorectal cancer. Oncol Res 2010;18: 437-44.
24. Koike H, Iijima M, Sugiura M, Mori K, Mattori N, Ito H, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003;54:19-29. (Pubitemid 36764978)
25. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-8.
26. Johansson O, Wang L, Hilliges M, Liang Y. Intraepidermal nerves in human skin: PGP 9.5 immunohistochemistry with special reference to the nerve density in skin from different body regions. J Peripher Nerv Syst 1999;4:43-52. (Pubitemid 29152256)
27. Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004;25:94-102. (Pubitemid 38096266)
28. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 2001;169: 386-91. (Pubitemid 32524432)
29. Cui J-G, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 2000;88:239-48.
30. Shubayev VI, Myers RR. Upregulation and interaction of TNFa and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000;855:83-9. (Pubitemid 30067697)
31. Sommer C, Schmidt C, George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998;151: 138-42. (Pubitemid 28223862)
32. Sommer C, Marziniak M, Myers RR. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 1998;74:83-91. (Pubitemid 28097733)
33. Sommer C, Lindenlaub T, Teuteberg P, Schafers M, Hartung T, Toyka KV. Anti-TNF-antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 2001;913:86-9. (Pubitemid 32786935)
34. Sommer C, Schafer M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001;6:67-72. (Pubitemid 32606886)
35. Sorkin LS, Doom CM. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst 2000;5:96-100. (Pubitemid 30451711)
36. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumor necrosis factor α. Br J Pharmacol 1997;121: 417-24. (Pubitemid 27226293)
37. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000;130:1418-24. (Pubitemid 30488609)
38. Benn T, Halfpenny C, Scolding N. Glial cells as targets for cytotoxic immune mediators. Glia 2001;36:200-11. (Pubitemid 33055908)
39. Lisak RP, Bealmear B, Benjamins J, Skoff A. Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro. Neurology 1998;51:1661-5. (Pubitemid 28565249)
40. Conti G, De Pol A, Scarpini E, Vaccina F, De Riz M, Baron P, et al. Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells. J Neuroimmunol 2002;124:29-35. (Pubitemid 34212007)
41. Shubayev VI, Myers RR. Endoneurial remodeling by TNFa- and TNFα-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripher Nerv Syst 2002;7:28-36. (Pubitemid 34246035)
42. Bolton CF, Winkelmann RK, Dyck PJ. A quantitative study of Meissner's corpuscles in man. Neurology 1966;16:1-9.
43. Boyette-Davis J, Xin W, Zhang H, Dougherty PM. Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyper-algesia and can be prevented by treatment with minocycline. Pain 2011;152:308-13.
44. Boyette-Davis J, Dougherty PM. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol 2011;229:353-7.
45. Siau C, Xiao W, Bennett GJ. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 2006;201:507-14. (Pubitemid 44344243)